Thursday, July 2, 2020

Are Black Americans victims of Police Militarization in the US

This article is by

Share this article

Article Contributor(s)

Nikhita Gautam

Article Title

Are Black Americans victims of Police Militarization in the US

Publisher

Global Views 360

Publication Date

July 2, 2020

URL

Chicago Police

Chicago Police | Source: noahwesley via Creative Commons

In the USA, there are reports of police using tear gas, flashbangs, and many other weapons to fight against the riots which are occurring now in over 350 cities against police brutality against the Black Community. There have been many reports on how the police brutality is disproportionate in terms of race; the Black people are thrice as likely to have violence committed on them by the police force than the whites, and the factor is 1.5 for the Hispanics. There is a first-hand account of a person present in the recent protests who talks about the use of batons on demonstrators.

This, however, leads to the question whether it was the militarization of the police force that caused violence towards minority communities. The police militarization was, in the aftermath of the 9/11 US terrorist attack, justified by the policymakers as a necessary tool to prevent the terrorist attacks in the future. This policy decision led to the military grade weapons and military style training regime for the police force. Some of the states in the US partnered with highly militarized police of Israel for training their police force. Such lethal weapons which were provided to the police force  used against terrorists were gradually used by the police force against common civilians on suspicion of minor crimes and the group of protestors.

The civil right groups were voicing concerns for many years about the use of disproportionate force on the Black and Hispanic Americans, which they blamed on the arming of police with lethal weapons. It was the death of Michael Brown, an unarmed black teenager, who was shot and killed on Aug. 9, 2014, by Darren Wilson, a white police officer, in Ferguson, Montana, USA that galvanised the public to demand for demilitarization of police force. As a response to public anger against the killing of Michael Brown, President Obama set up a Task Force on 21st Century Policing. This task force, in its report put special emphasis on de-escalating situations, with civilians in training and policies, and reduced funding by the Department of Homeland Security for such weapons. However these recommendations failed to have much effect on solving the issues at hand.

The continued use of such lethal weapons casts the police force as a separate, powerful entity which is to be feared, instead of a friendly cop who is trying to provide security to a citizen in distress. Such equipment serves to distance the police from the people, giving them power, and if left unchecked, entitlement over the rest of the citizens. In many instances the presence of a weapon itself leads to more aggressive behaviour and there have been calls to make the police wear body cams to restrain them from acting with disproportionate lethal force.

The racial profiling and discriminatory actions against the black and other communities that was already practiced by the police forces was now being enforced by more lethal power in the force’s hands. A study by Olugbenga Ajilore shows that counties with more race segregation were more likely to request additional weapons, and counties with an African American/Asian American population are more likely to acquire military equipment. Another report of 2017 shows a direct correlation between the degree of police militarization and the killing of civilians in police action.

It can be reasonably said that the militarization, in some sense, inflated the already existing racial profiling based violent actions of police force.

Support us to bring the world closer

To keep our content accessible we don't charge anything from our readers and rely on donations to continue working. Your support is critical in keeping Global Views 360 independent and helps us to present a well-rounded world view on different international issues for you. Every contribution, however big or small, is valuable for us to keep on delivering in future as well.

Support Us

Share this article

Read More

February 4, 2021 5:14 PM

Asian countries & the race for COVID-19 Vaccine

Our relationship with the new strain of coronavirus is almost 8 months strong now. Countries like the US, Russia, UK, China, India, and many more have already set their brainy scientists in the task of developing a vaccine, turning it into a race which desperately needs a winner, since no one wants this deadly relationship to endure. Several attempts have proved to be successful, especially in countries like Russia, USA, India, and China.

China was the first to start scouring for a vaccine the day WHO declared that the new strain of SARS-CoV, originating in Wuhan-China, has resulted in a pandemic. It is a fierce competitor, especially to the US, as almost 8 of the 24 promising vaccines approved for clinical trials are from China. It used the technology of ‘inactivated vaccine’ which basically means killing the actual virus and using that to create a vaccine. This method is quite useful in treating measles and influenza, thus, increasing the chances of success in the case of COVID-19 as well.

“It’s a tried and true strategy”, Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia, said  about the inactivated vaccine. One potential vaccine from China-based Sinopharm is already in the phase 3 of trials whereas Sinovac will enter the third phase this month. Moreover, China has permitted Sinovac and Sinopharm to dilute phase 1 and 2 of vaccine trials on humans to hasten the process.

The head of the Chinese Center for Disease Control and Prevention, Gao Fu, had also been injected with a potential vaccine on July 28, 2020. “I’m going to reveal something undercover: I am injected with one of the vaccines'' Gao Fu said in a webinar hosted by Alibaba Health, an arm of the Chinese e-commerce giant, and Cell Press, an American publisher of scientific journals. However, he did not reveal any more details about how and when exactly he administered himself with the vaccine and ‘hopes’ that the vaccine works.

Vladimir Putin, President of Russia | Source: Wikimedia

Elsewhere in Russia, on August 11, 2020, President Vladimir Putin proudly announced that Russia was the first country to grant regulatory approval to their vaccine after carrying out human trials for less than 2 months by the Gamalei Institute in Moscow. Regulatory approval permits vaccination of the masses. Although it has not undergone phase 3 of trials, Russia expects to initiate mass production of the vaccine by the end of this year. Kirill Dmitriev, head of Russia's sovereign wealth fund states that the vaccine will be called ‘Sputnik V’, named after Sputnik 1, the first satellite launched by Soveit Union which was a euphoric moment for Russia. More recently, China and Russia have joined hands in proceeding with the clinical trials of their vaccines.

These two instances seem to bring a new hope for the future, yet raise alarms and invite scepticism from the experts in the field of public health. One major concern is that without prolonged trials, vaccines should not be authorized for public use. Anthony Fauci, an infectious disease expert based in the US said “I do hope the Chinese and the Russians are actually testing the vaccines before they are administering the vaccine to anyone. Because claims of having a vaccine ready to distribute before you do testing is problematic at the very least”. Hence, some people are still in doubt regarding the safety of the product. Putin, however, rubbished such concerns and said "I know that it works quite effectively, forms strong immunity, and I repeat, it has passed all the needed checks".

An Indian biotechnological company, Bharat Biotech developed ‘Covaxin’ in collaboration with Indian Council for Medical Research (ICMR), using the mechanism of inactivated vaccine. It was successful in getting approval for human trials which were scheduled to begin in July, 2020. Initial reports stated that it would be ready for mass use by August 15, 2020, which also marked the 73rd Independence Day of India. However, Bharat biotech was clear in letting the public know that phase 1 of the trials are still on-going. ICMR cleared the confusion by stating that it would prepare the results of the phase 1 trials by August 15, 2020, not the actual vaccine for use. Phase 2 of the trials are awaited in September, 2020.

So far, the results of phase 1 trials have been positive as no serious side-effects are observed in the vaccine candidates. “The vaccine has been safe. No adverse effect has been reported. Even the point of injection pain, which is normal in vaccines, has been very mild” said Dr Kushwaha of Prakhar Hospital.

Meanwhile, the South Korean government stated on August 21, 2020, that it will secure adequate vaccine supply to its citizens by cooperating with international bodies and promoting local drug development. Three South Korean companies have started the process of making a vaccine and all are in the clinical trial phase. Bill Gates asserts that the South Korean pharmaceutical company, SK Bioscience, will have around 200 million vaccine doses ready by June 2021.

Japan is jointly collaborating with the UK, France and other European countries to establish a $20 billion fund to buy coronavirus vaccines, with Japan pledging a contribution of $800 million. It’s vaccine program aims to focus on giving primary attention to its medical workers and the elderly people of the country when the first doses of the vaccine are made. The state-funded vaccination program is believed to be officially adopted by Japan in September this year with negotiations with the UK and US based drug makers already in place.

With the race to bring COVID-19 vaccine seemingly coming to a close and it will hopefully be ready by the end of 2020 or early 2021. Till then, the entire world is watching this race with bated breath.

Read More